首页> 外文会议>International Stereotactic Radiosurgery Society >Lipid Peroxidation and Cyclooxygenase-2 Activity in Human Hepatocellular Carcinoma Cell Lines With and Without Multiple Drug Resistance: Correlation With Cell Growth
【24h】

Lipid Peroxidation and Cyclooxygenase-2 Activity in Human Hepatocellular Carcinoma Cell Lines With and Without Multiple Drug Resistance: Correlation With Cell Growth

机译:脂质过氧化与人肝细胞癌细胞系中的脂质过氧化和环氧化酶-2活性,无多种耐药性:与细胞生长的相关性

获取原文

摘要

Intrinsic or acquired resistance to antineoplastic drugs is the main cause of failure in cancer chemotherapy. Human hepatocellular carcinoma (HCC) has been increasing on a worldwide scale and it is among the most chemoresistant tumors. One of the main mechanisms of drug resistance is related to the over-expression of the gene that encodes a transmembrane P-glycoprotein which is involved in drug extrusion from the cells that possess the multiple drug-resistant (MDR1) phenotype [1]. Cancers with an MDR phenotype are more resistant to several anticancer drugs. Free radical formation is purported to be involved in cytotoxic effects of anticancer agents. However in HCC cells the expression of MDR1 phenotypeper se does not increase significantly the resistance to iron-stimulated lipid peroxidation [2]. Moreover hepatitis B and C viruses are found to be important factors of hepatocarcinogenesis, through the induction of cell proliferation and angiogenesis. Cyclooxygenase-2 (COX-2) has now been identified as expressed in a number of cancers, including HCC [3], but whether COX-2 activity affects cell growth and susceptibility to free radical attack in human HCC cell lines has not been elucidated. To assess these points, an HCC MDR1 cell line highly resistant to doxorubicin, Pl(0.5), and the parental drug-sensitive cells, P5, were studied for their susceptibility to lipid peroxidation and for the effect afforded by nimesulide, a COX-2 inhibitor.
机译:对抗肿瘤药物的内在或获得的抗性是癌症化疗失败的主要原因。人肝细胞癌(HCC)在全球范围内越来越大,它是最沉重的肿瘤中。耐药性的主要机制之一与编码跨膜p-糖蛋白的基因的过表达有关,其参与来自具有多种耐药性(MDR1)表型的细胞的药物挤出[1]。具有MDR表型的癌症对几种抗癌药物更耐药。自由基形成旨在参与抗癌剂的细胞毒性作用。然而,在HCC细胞中,MDR1现象蛋白酶的表达不会显着增加对铁刺激脂质过氧化的抗性[2]。此外,通过诱导细胞增殖和血管生成,发现乙型肝炎和C病毒是肝癌发生的重要因素。现在已经鉴定了环氧酶-2(COX-2),如多种癌症所示,包括HCC [3],但COX-2活性是否会影响细胞生长和对人HCC细胞系中自由基攻击的易感性尚未阐明。为了评估这些点,研究了对多柔比星,PL(0.5)和亲本药物敏感细胞P5具有高抗性的HCC MDR1细胞系P5对脂质过氧化的敏感性,并且用于尼米氧化物,COX-2提供的效果抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号